Skip to main content
. 2022 Oct 17;157:105322. doi: 10.1016/j.jcv.2022.105322

Fig. 5.

Fig 5

Age group-sorted positive Viramed-Test results (S1/S2-specific antibodies after first shot of vaccination). The colored area depicts the time interval in which, at least for Biontech-vaccinated, no seroconversion was expected (until day 14 after first vaccination) [19].